Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Zomedica Corp - SIC # 742 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ZOM
American
742
https://zomedica.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Zomedica Corp
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
- Mar 20th, 2024 10:30 am
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
- Mar 14th, 2024 10:30 am
Zomedica Provides NYSE American Listing Update
- Mar 13th, 2024 8:45 pm
Sidoti Events, LLC's Virtual March Small-Cap Conference
- Mar 12th, 2024 2:30 pm
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
- Mar 12th, 2024 10:30 am
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
- Mar 7th, 2024 10:30 am
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
- Mar 5th, 2024 11:30 am
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
- Feb 8th, 2024 11:30 am
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)
- Feb 6th, 2024 9:30 pm
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET
- Feb 6th, 2024 11:30 am
Open Letter to Zomedica Shareholders from your Chief Executive Officer
- Jan 31st, 2024 11:30 am
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference
- Jan 30th, 2024 11:30 am
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split
- Jan 25th, 2024 9:35 pm
Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")
- Jan 17th, 2024 9:00 pm
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of Shareholders on February 28, 2024
- Jan 10th, 2024 11:30 am
Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece
- Jan 4th, 2024 11:30 am
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease
- Dec 18th, 2023 11:30 am
Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners
- Dec 6th, 2023 11:30 am
Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference
- Nov 28th, 2023 11:30 am
Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference
- Nov 20th, 2023 11:30 am
Scroll